Current portfolio
Hutchmed
Among the first global-focused novel drug discovery companies in China
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
- SectorHealthcare
- CountryGreater China
- FundThe Baring Asia Private Equity Fund VII
- Entry2021
- Web
